Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the expression of the BCR::ABL1 fusion protein, which exhibits constitutive tyrosine kinase activity [1]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.